451 related articles for article (PubMed ID: 19340686)
41. Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
Monheit GD; Dreher F
J Drugs Dermatol; 2013 Mar; 12(3):270-4. PubMed ID: 23545908
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma.
Chaudhary S; Dayal S
J Drugs Dermatol; 2013 Oct; 12(10):1149-53. PubMed ID: 24085051
[TBL] [Abstract][Full Text] [Related]
43. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
[TBL] [Abstract][Full Text] [Related]
44. Q-switched alexandrite laser-assisted treatment of melasma: 2-year follow-up monitoring.
Rusciani A; Motta A; Rusciani L; Alfano C
J Drugs Dermatol; 2005; 4(6):770-4. PubMed ID: 16302566
[TBL] [Abstract][Full Text] [Related]
45. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
Grimes PE
Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
[TBL] [Abstract][Full Text] [Related]
47. The Safety and Efficacy of Treatment With a 1,927-nm Diode Laser With and Without Topical Hydroquinone for Facial Hyperpigmentation and Melasma in Darker Skin Types.
Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Fabi SG
Dermatol Surg; 2018 Oct; 44(10):1304-1310. PubMed ID: 29659405
[TBL] [Abstract][Full Text] [Related]
48. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial.
Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R
Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697
[TBL] [Abstract][Full Text] [Related]
49. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
Spierings NMK
J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
[TBL] [Abstract][Full Text] [Related]
50. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
Rendon M; Dryer L
J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
[TBL] [Abstract][Full Text] [Related]
51. A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature.
Garg S; Vashisht KR; Makadia S
J Cosmet Laser Ther; 2019 Aug; 21(5):297-307. PubMed ID: 31010346
[No Abstract] [Full Text] [Related]
52. Optimizing Q-switched lasers for melasma and acquired dermal melanoses.
Aurangabadkar SJ
Indian J Dermatol Venereol Leprol; 2019; 85(1):10-17. PubMed ID: 30027914
[TBL] [Abstract][Full Text] [Related]
53. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
Mendoza CG; Singzon IA; Handog EB
Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
[TBL] [Abstract][Full Text] [Related]
54. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
Brown AS; Hussain M; Goldberg DJ
J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma.
Erbil H; Sezer E; Taştan B; Arca E; Kurumlu Z
J Dermatol; 2007 Jan; 34(1):25-30. PubMed ID: 17204097
[TBL] [Abstract][Full Text] [Related]
56. A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation.
Agamia N; Apalla Z; Salem W; Abdallah W
J Dermatolog Treat; 2021 Nov; 32(7):819-826. PubMed ID: 31908179
[TBL] [Abstract][Full Text] [Related]
57. Focal trichloroacetic acid peel method for benign pigmented lesions in dark-skinned patients.
Chun EY; Lee JB; Lee KH
Dermatol Surg; 2004 Apr; 30(4 Pt 1):512-6; discussion 516. PubMed ID: 15056140
[TBL] [Abstract][Full Text] [Related]
58. Community-based trial of a triple-combination agent for the treatment of facial melasma.
Grimes P; Kelly AP; Torok H; Willis I
Cutis; 2006 Mar; 77(3):177-84. PubMed ID: 16610738
[TBL] [Abstract][Full Text] [Related]
59. Sequential treatment with triple combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive (control) cream and intense pulsed light in patients with moderate to severe melasma.
Goldman MP; Gold MH; Palm MD; Colón LE; Preston N; Johnson LA; Gottschalk RW
Dermatol Surg; 2011 Feb; 37(2):224-33. PubMed ID: 21269349
[TBL] [Abstract][Full Text] [Related]
60. Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity.
Arellano I; Cestari T; Ocampo-Candiani J; Azulay-Abulafia L; Bezerra Trindade Neto P; Hexsel D; Machado-Pinto J; Muñoz H; Rivitti-Machado MC; Sittart JA; Trindade de Almeida AR; Rego V; Paliargues F; Marques-Hassun K
J Eur Acad Dermatol Venereol; 2012 May; 26(5):611-8. PubMed ID: 21623930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
